Peter W. Bergum
Research Subjects
Peter W. Bergum has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Amy Cruikshank
From ‡Corvas International, Inc., San Diego, California 92121 and the ¶Department of Immunology, Scripps Research Institute, La Jolla, California 92037
1 shared publicationBarbara A. Furmidge
1 shared publicationCurtis R. Kelly
From ‡Corvas International, Inc., San Diego, California 92121 and the ¶Department of Immunology, Scripps Research Institute, La Jolla, California 92037
1 shared publicationDavid I. Pritchard
1 shared publicationGeorge P. Vlasuk
From ‡Corvas International, Inc., San Diego, California 92121 and the ¶Department of Immunology, Scripps Research Institute, La Jolla, California 92037
1 shared publication- George P. Vlasuk
Corvas International, Inc., 3030 Science Park Road, San Diego, California, 92121, USA
1 shared publication
Latest Publications
- Open Access
- 1 March 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (13) , 10063-10071
Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2
- 1 March 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (13) , 10063-10071
Open AccessRole of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2
- 1 May 1996
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 54 (5) , 475-480
Isolation and Characterization of the Tsetse Thrombin Inhibitor: A Potent Antithrombotic Peptide from the Saliva of Glossina morsitans morsitans
A potent and specific inhibitor of the human coagulation protease thrombin was identified in salivary gland extracts of the tsetse fly, Glossina morsitans morsitans, an important vector of African trypanosomiasis. This low molecular weight peptide (MW = 3,530 Da as determined by laser desorption mass spectrometry) was purified using a combination of size-exclusion chromatography and reverse-phase, high-performance liquid chromatography, respectively. Amino terminal sequencing of the purified protein reveals no homology to any previously identified serine protease inhibitor or naturally occurring anticoagulant. The tsetse thrombin inhibitor (TTI) is a stoichiometric inhibitor of thrombin, with an apparent equilibrium dissociation inhibitory constant of 584 × 10-15 M. In addition, it is also a potent inhibitor of thrombin-induced platelet aggregation. Like other hematophagous arthropods, tsetse flies appear to have evolved a novel protease inhibitor capable of antagonizing host hemostasis and facilitating blood feeding.
- 1 May 1996
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 54 (5) , 475-480
Isolation and Characterization of the Tsetse Thrombin Inhibitor: A Potent Antithrombotic Peptide from the Saliva of Glossina morsitans morsitans
A potent and specific inhibitor of the human coagulation protease thrombin was identified in salivary gland extracts of the tsetse fly, Glossina morsitans morsitans, an important vector of African trypanosomiasis. This low molecular weight peptide (MW = 3,530 Da as determined by laser desorption mass spectrometry) was purified using a combination of size-exclusion chromatography and reverse-phase, high-performance liquid chromatography, respectively. Amino terminal sequencing of the purified protein reveals no homology to any previously identified serine protease inhibitor or naturally occurring anticoagulant. The tsetse thrombin inhibitor (TTI) is a stoichiometric inhibitor of thrombin, with an apparent equilibrium dissociation inhibitory constant of 584 × 10-15 M. In addition, it is also a potent inhibitor of thrombin-induced platelet aggregation. Like other hematophagous arthropods, tsetse flies appear to have evolved a novel protease inhibitor capable of antagonizing host hemostasis and facilitating blood feeding.